Search for: "Wyeth Pharmaceuticals Company Inc"
Results 241 - 260
of 281
Sorted by Relevance
|
Sort by Date
31 Dec 2015, 5:12 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., ___ F.3d ___, 2015 WL 8538119 (6th Cir. [read post]
15 Jul 2010, 2:39 pm
Wyeth, Inc., 613 F. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
3 Apr 2009, 5:10 am
Department of Justice, Burroughs Corp., Colgate-Palmolive Co. and Pitney Bowes Inc. [read post]
2 Oct 2008, 12:36 pm
Astrazeneca Pharmaceuticals, LP, 500 F.Supp.2d 736 (S.D. [read post]
31 Oct 2011, 4:58 am
Consider those 2,200+ Reglan cases in Philadelphia: back in July, the Supreme Court’s decision in Pliva, Inc. v. [read post]
25 Sep 2007, 1:00 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
5 Jun 2013, 5:29 am
American Medical Systems, Inc., 958 F. [read post]
27 Sep 2007, 11:38 am
Fujisawa Pharmaceutical Co., 464 F. [read post]
23 May 2008, 1:03 am
– Discussion of Catherine Tremblay’s article on cost approach: (IP finance), US Congress cites free expression as reason ICANN must remain controlled by US government: (IP Justice), A new organisation around IP in your company? [read post]
26 May 2015, 7:42 am
SJS/TEN is somewhat analogous in our sandbox to mesothelioma in asbestos cases, since plaintiffs often work backwards from the diagnosis to look for some drug company to sue. [read post]
16 Aug 2009, 11:23 am
The best example of the downside of optionality was the sale of United Rentals Inc. where the buyer, Cerberus, unabashedly chose to pay the break fee rather than close, despite the absence of any material problem in the URI business. [read post]
14 May 2007, 7:03 am
Fujisawa Pharmaceutical Co., 464 F. [read post]
16 Apr 2007, 3:04 am
Defendant pharmaceutical company Wyeth's appeal of the judgment was noteworthy because it would have tested Texas' statutory cap limiting punitive damages. [read post]
19 Apr 2013, 5:35 pm
Wyeth Pharm. [read post]
19 May 2011, 1:15 pm
Wyeth-Ayerst Laboratories Co., 278 F. [read post]
8 Jun 2012, 10:35 am
Wyeth Labs., 498 F.2d 1264, 1276 (5th Cir. 1974) omitted]. [read post]
21 Apr 2010, 12:08 pm
Wyeth Inc., 2008 WL 2856146 (N.J. [read post]
13 Sep 2007, 10:48 am
Jude Medical, Inc., 425 F.3d 1116, 1119-21 (8th Cir. 2005), and Castano v. [read post]
13 Mar 2009, 4:00 am
(Securing Innovation) PriorSmart.com search tool, tracking patent documents (Competitive Info) (Patently-O) Patent damages as an incentive to transact (IP finance) IPscore, new patent evaluation toy (IP finance) Patent portfolios can pull companies out of financial rut (Law360) Global - Copyright Expanding the public domain: part zero (Creative Commons) Australia Pioneering decision on non-use: Pioneer Computers Australia Pty Limited v Pioneer KK (Australian… [read post]
